Dapagliflozin and sacubitril on myocardial microperfusion in patients with post-acute myocardial infarction heart failure and type 2 diabetes

Table 2 Comparison of myocardial micro perfusion indexes between the two groups

Item	Control group (n = 47)		t	P value	Observation group (n = 51)		t	P value
	Before treatment	After treatment			Before treatment	After treatment
CTFC	80.25 ± 4.89	48.23 ± 4.66a	32.05	< 0.01	78.98 ± 5.47	37.12 ± 5.02a,c	42.07	< 0.01
TMPG	130.14 ± 7.85	105.25 ± 6.11a	19.65	< 0.01	128.97 ± 10.04	96.12 ± 5.78a,c	19.04	< 0.01
CFVR	2.25 ± 0.41	2.98 ± 0.47a	-6.52	< 0.01	2.20 ± 0.46	3.32 ± 0.51a,c	-13.53	< 0.01

^aP < 0.05 vs before treatment.

^cP < 0.05 vs control group.

CTFC: Thrombolysis in myocardial infarction frame count; TMPG: Thrombolysis in myocardial infarction myocardial perfusion grade; CFVR: Coronary flow velocity reserves.